Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oncology Institute (TOI) Other financing activities (2020)

Oncology Institute (TOI) has disclosed Other financing activities for 1 consecutive years, with -$3.8 million as the latest value for Q4 2020.

  • For the quarter ending Q4 2020, Other financing activities changed N/A year-over-year to -$3.8 million, compared with a TTM value of -$3.8 million through Dec 2023, down 0.94%, and an annual FY2022 reading of $3.7 million, changed N/A over the prior year.
  • Other financing activities was -$3.8 million for Q4 2020 at Oncology Institute, down from $35122.0 in the prior quarter.
  • Across five years, Other financing activities topped out at $4.1 million in Q1 2020 and bottomed at -$3.8 million in Q4 2020.